Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study
- 28 February 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 46 (2), 206-212
- https://doi.org/10.1016/j.jhep.2006.08.020
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapyGut, 2004
- 1013 Interferon treatment outcomes in patients with decompensated HCV + cirrhosisHepatology, 2003
- Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on liver transplantation and hepatitis CLiver Transplantation, 2003
- Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantationJournal of Hepatology, 2003
- Infection with chronic hepatitis C virus and liver transplantation: A role for interferon therapy before transplantationLiver Transplantation, 2003
- National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002Hepatology, 2002
- Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CHepatology, 2002
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachJournal of Hepatology, 2001
- Determinants of outcome of compensated hepatitis C virus-related cirrhosisHepatology, 1998
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type CJournal of Hepatology, 1997